PERORAL  ADMINISTRATION OF AURANTIN IN TREATMENT OF EHRLICH'S CARCINOMA.
D000818:Animals; D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D000970:Antineoplastic Agents; D001774:Blood Chemical Analysis; D002286:Carcinoma, Ehrlich Tumor; D003609:Dactinomycin; D051379:Mice; D010600:Pharmacology; D012106:Research; D013154:Spleen; D013950:Thymus Gland; D014116:Toxicology
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D000970:Antineoplastic Agents; D003609:Dactinomycin; C090194:aurantin
ANTIBIOTICS; ANTINEOPLASTIC AGENTS; BLOOD CHEMICAL ANALYSIS; CARCINOMA, EHRLICH TUMOR; EXPERIMENTAL LAB STUDY; MICE; PHARMACOLOGY; SPLEEN; THYMUS GLAND; TOXICOLOGIC REPORT